Sunday, August 21, 2005

Where should academic freedom end?

The Seattle Times stirred up controversy on August 7 as they published an article about how university faculty talk about the results of clinical trials prior to their completion. Universities need to be cautious about leaking early information, and confidentiality of patient information, certainly. But where is the line between academic freedom and insider trading? Universities must remember their core mission to educate and research. See the report here.

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home